ALHC Alert: HBSS Investigates Alignment Healthcare (ALHC) Over Whistleblower Allegations of Financial Manipulation
ALHC Alert: HBSS Investigates Alignment Healthcare (ALHC) Over Whistleblower Allegations of Financial Manipulation
SAN FRANCISCO--(BUSINESS WIRE)--Shareholder rights firm Hagens Berman (HBSS) is investigating potential securities law violations by Alignment Healthcare, Inc. (NASDAQ: ALHC) following a whistleblower lawsuit alleging systemic financial manipulation.
Following the whistleblower's claims, ALHC stock fell approximately 16.7% in a single day.
Share
SUBMIT YOUR ALHC INVESTMENT LOSSES TO HBSS
Visit: www.hbsslaw.com/investor-fraud/alhc
Contact the Firm Now: ALHC@hbsslaw.com, 844-916-0895
Alignment Healthcare, Inc. (ALHC) Investigation:
On July 8, 2026, news broke that a former Alignment executive had filed a lawsuit alleging the company engaged in deliberate accounting irregularities to inflate its financial results.
The whistleblower, Hakan Kardes, Alignment’s former chief transformation officer, alleges the company misclassified operating expenses as capital expenditures, which purportedly boosted adjusted EBITDA for 2024 and 2025 and inflated key performance metrics tied to the company's stock price and executive compensation.
Following the whistleblower's claims, ALHC stock fell approximately 16.7% in a single day.
“We’re investigating whether Alignment Healthcare misled investors with false information regarding its financial health and internal controls. Investors who purchased ALHC securities and suffered significant losses should contact our firm to discuss their legal rights,” said Reed Kathrein, the Hagens Berman partner leading the investigation.
If you invested in Alignment and have substantial losses, or have knowledge that will assist the firm’s investigation, submit your losses now »
If you’d like more information and answers to other frequently asked questions about the firm’s Alignment investigation, read more »
Whistleblowers: Persons with non-public information regarding Alignment Healthcare should consider their options to aid the investigation or take advantage of the SEC Whistleblower program. Under the program, whistleblowers who provide original information may receive rewards up to 30 percent of any successful SEC recovery. For more information, call Reed Kathrein at 844-916-0895 or email ALHC@hbsslaw.com.
Hagens Berman is a global plaintiffs’ rights complex litigation firm focusing on corporate accountability. The firm is home to a robust practice and represents investors as well as whistleblowers, workers, consumers and others in cases achieving real results for those harmed by corporate negligence and other wrongdoings. Hagens Berman’s team has secured more than $2.9 billion in this area of law. More about the firm and its successes can be found at hbsslaw.com. Follow the firm for updates and news at @ClassActionLaw.
Attorney Advertising. Prior results do not guarantee a similar outcome in any future case.
Contacts
Reed Kathrein, 844-916-0895
